Intellectual property kept its place in the public spotlight in 2012, with patent trolls running rampant and smartphone wars that seemed to never end.
These big stories, with their technology-based patents in dispute, naturally dominated the headlines. But battles over gadgets weren’t the only actions in court. Companies skirmished over biomedical and life sciences patents, too. And other court battles featured copyrights and the definition of what constitutes “fair use” in an age of ever-changing technology.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
